Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 055494/0377 | |
| Pages: | 9 |
| | Recorded: | 03/04/2021 | | |
| Attorney Dkt #: | NAC0135US2 |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE SECOND INVENTOR'S EXECUTION DATE AND RECEIVING PARTY NAME AND ADDRESS PREVIOUSLY RECORDED AT REEL: 055215 FRAME: 0648. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17262379
|
Filing Dt:
|
01/22/2021
|
|
Publication #:
|
|
Pub Dt:
|
07/13/2023
| | | | |
|
Title:
|
OXYNITIDINE DERIVATIVES USEFUL AS INHIBITORS OF TOPOISOMERASE IB (TOP1) AND TYROSYL-DNA PHOSPHODIESTERASE 1 (TDP1)
|
|
|
Assignee
|
|
|
|
|
| NATIONAL INSTITUTES OF HEALTH, OTT |
| 6011 EXECUTIVE BOULEVARD, SUITE 325, MSC 7660 |
| BETHESDA, MARYLAND 20892-7660 |
|
|
Correspondence name and address
|
| |
CANTOR COLBURN LLP
|
| |
20 CHURCH STREET
|
| |
22ND FLOOR
|
| |
HARTFORD, CT 06103
|
Search Results as of:
05/16/2024 03:09 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
